Recruiting
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
ClinicalTrials.gov IDNCT06997549
PhaseNot Applicable
Enrollment12000
SponsorNeuronetics
Age5 Years
SexALL
Conditions studied
Depression, OCD, Anxiety Depression
About this study
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Interventions
- Device: Patients treated with NeuroStar TMS — non-invasive brain stimulation device
- Drug: Patients treated with Esketamine — nasal spray for treating depression
Primary outcomes
- change in clinical outcome scores from baseline to post treatment (8 weeks)
Eligibility information
Inclusion Criteria:
* Male or female reported in database and not an invalid entry
* Age reported and not an invalid entry
* Treatment date in 2011 or later.
Exclusion Criteria:
• Incomplete information on treatment parameters
Study locations
- Neuronetics, Malvern, Pennsylvania 19355 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-29.